Grant: Operating Grant

In healthy humans, brain blood flow is highly influenced by changes in the levels of oxygen and carbon dioxide in the circulating blood. However, the brain's important ability to regulate its blood flow is impaired in various disease processes such as obstructive sleep apnea (OSA). People who have OSA stop breathing intermittently throughout the night, resulting in repeated episodes of low oxygen and high carbon dioxide in the blood. Because of these repeated episodes, the ability of the brain vessels to regulate blood flow becomes impaired. This impairment can lead to hypertension and stroke. The mechanisms that regulate brain blood flow in health, and how these mechanisms become impaired with disease, is poorly understood. It is thought that nitric oxide (NO) plays a major role in regulating blood flow in several vascular beds, including the brain. In a first study, we will develop an experimental human model of intermittent hypoxia and we will determine the effects of intermittent hypoxia on the regulation of brain blood flow and the cardiovascular system. In a second study, we will determine the extent to which the brain blood flow response to low oxygen is altered in a broad range of patients with moderate to severe OSA. We will compare the responses in the brain with those in the forearm. Finally, our research will determine if the brain blood flow impairements observed in untreated OSA patients can be corrected after treatment with night-time continuous positive airway pressure. This work may help us better understand conditions such as hypertension, OSA, stroke and aging, in which endothelium-dependent relaxation (i.e., relaxation of the cells that line brain blood vessels) by NO is impaired. Further, our research will provide useful information about how well treatment for OSA reverses brain blood flow impairments that may lead to stroke. Ultimately, this will translate into improved health and disease prevention for Canadians.